SILICON COMPOUNDS USEFUL IN CANCER THERAPY

Details for Australian Patent Application No. 2003302625 (hide)

Owner AMEDIS PHARMACEUTICALS LTD.

Inventors BAINS, William; MONTANA, John, Gary

Pub. Number AU-A-2003302625

PCT Number PCT/GB2003/0050

PCT Pub. Number WO2004/050666

Priority 0227906.5 29.11.02 GB

Filing date 20 November 2003

Wipo publication date 23 June 2004

International Classifications

C07F 007/18 Compounds containing elements of the 4th Group of the Periodic System

A61K 047/48 Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates

Event Publications

22 July 2004 Complete Application Filed

  Priority application(s): 0227906.5 29.11.02 GB

29 July 2004 Application Open to Public Inspection

  Published as AU-A-2003302625

22 September 2005 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(f)/See Reg. 8.3(3). Examination has not yet been requested or directed for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003302626-1, 2, 5-THIADIAZOLIDIN-3-ONE 1, 1 DIOXIDE DERIVATIVES AS INHIBITORS OF PROTEIN TYROSINE PHOSPHATASE PTP1B

2003302624-SILICON COMPOUNDS